Advanced Medical Equipment

Advanced Medical Equipment FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Advanced Medical Equipment (AME.WA) as of Nov 22, 2026 is -8,330.12 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was -2,909.84 % — a change of 186.27% (lower).

FCF Conversion

-8,330.12 %

YoY

186.27%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Advanced Medical Equipment is 2024 -8,330.12 % . FCF Conversion Rate (FCF/EBITDA) of Advanced Medical Equipment was 2023 -2,909.84 % . It decreases by 186.27% lower compared to the previous year.

The Advanced Medical Equipment FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2023
-2,909.84 PLN
Jan 1, 2024
-8,330.12 PLN
The Advanced Medical Equipment FCF Conversion history
YEARFCF ConversionYoY
-8,330.12 %+186.27%
-2,909.84 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Advanced Medical Equipment Stock analysis

What does Advanced Medical Equipment do? Advanced Medical Equipment SA generates revenue through the sale of its innovative Diabetomat device, which measures diabetes biomarkers in exhaled air without pain or anxiety. The device is internationally recognized as a noninvasive solution for over 600 million people globally, targeting patients and healthcare providers seeking advanced diabetes management tools. The company operates in the Health Care Equipment & Supplies industry with a focus on Poland-based medical technology development and distribution. The firm's primary product, Diabetomat, serves a global market segment of diabetes patients and healthcare professionals, eliminating the need for traditional invasive blood glucose monitoring. As a Poland-based company headquartered in Warsaw, it leverages its scientific recognition to market the device internationally, capitalizing on the growing demand for noninvasive medical technologies in the healthcare sector. Advanced Medical Equipment is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Advanced Medical Equipment stock

FCF Conversion Rate (FCF/EBITDA) of Advanced Medical Equipment is -8,330.12 % in 2024.

FCF Conversion Rate (FCF/EBITDA) of Advanced Medical Equipment changed from -2,909.84 % to -8,330.12 %, representing a 186.27% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Advanced Medical Equipment since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Advanced Medical Equipment with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Advanced Medical Equipment

All Key Metrics — Advanced Medical Equipment